Cargando…
Prediction of Cervical Cancer Outcome by Identifying and Validating a NAD+ Metabolism-Derived Gene Signature
Cervical cancer (CC) is the second most common female cancer. Excellent clinical outcomes have been achieved with current screening tests and medical treatments in the early stages, while the advanced stage has a poor prognosis. Nicotinamide adenine dinucleotide (NAD+) metabolism is implicated in ca...
Autores principales: | Chen, Aozheng, Jing, Wanling, Qiu, Jin, Zhang, Runjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781171/ https://www.ncbi.nlm.nih.gov/pubmed/36556252 http://dx.doi.org/10.3390/jpm12122031 |
Ejemplares similares
-
Plasma-Based Metabolomics Profiling of High-Risk Human Papillomavirus and their Emerging Roles in the Progression of Cervical Cancer
por: Chen, Aozheng, et al.
Publicado: (2022) -
Association of Glycosylation-Related Genes with Different Patterns of Immune Profiles and Prognosis in Cervical Cancer
por: Jing, Wanling, et al.
Publicado: (2023) -
Identification of NAD(+) Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
por: Lin, Liang, et al.
Publicado: (2022) -
A prognostic NAD+ metabolism-related gene signature for predicting response to immune checkpoint inhibitor in glioma
por: Jiang, Cheng, et al.
Publicado: (2023) -
Development and Validation of a Novel Gene Signature for Predicting the Prognosis by Identifying m5C Modification Subtypes of Cervical Cancer
por: Yu, Jing, et al.
Publicado: (2021)